Literature DB >> 28741197

Axillobifemoral Bypasses: Reappraisal of an Extra-Anatomic Bypass by Analysis of Results and Prognostic Factors.

D Dickas1, F Verrel1, J Kalff1, A Koscielny2.   

Abstract

BACKGROUND: Axillobifemoral bypass (AFB) is method of second choice. It is reserved for patients at high operative risk or to bypass infected vessels or grafts. In this study, we analyzed prognostic factors for AFB patency and limb salvage rate to facilitate the choice of procedure.
METHODS: Between Jan 2006 and Aug 2013, 45 patients underwent AFB surgery in our department, 24 for critical limb ischemia (CLI) and 23 for infection. Endpoints of study were graft occlusion, graft infection, amputation and patient's death. Prognostic factors were compared by univariate analysis for each indication group. Mean follow-up was 40.2 (±23.2) months.
RESULTS: Complication rate was significantly higher in infection group (88.0 vs. 54.4%, p = 0.003) and in emergency surgery (83.3 vs. 56.9%, p = 0.023). Overall primary patency rate after AFB procedures was 66.7% after 1, 3, and 5 years, while secondary patency rate was 91.1% after 1 year, 82.2% after 3 years and 80.0% after 5 years. The primary and secondary patency rates did not significantly differ between the both groups (p = 0.059 and p = 0.136). Following prognostic factors showed a statistically significant influence on patency rates in CLI group: >1 previous vascular surgical intervention, patch angioplasty at the distal anastomosis site, complications after previous vascular surgery, and perioperative intake of platelet aggregation inhibitor. Only the employed bypass material had a statistical significant influence on the secondary patency rates in the infection group. Overall limb salvage rate was 82.2% after 1 year, 80.0% after 3 years and 77.8% after 5 years. There were statistically significant differences in the limb salvage rates depending on emergency surgery and a 3-vessel-run-off in the lower leg in both indication groups.
CONCLUSION: AFB have acceptable patency and limb salvage rates. AFB is a good alternative in patients with CLI at high operative risk or with infections of aortoiliac segments, even with endovascular approaches. They remain essential tools in vascular surgeon's repertoire.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28741197     DOI: 10.1007/s00268-017-4150-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  30 in total

1.  Surgical wound infections after vascular surgery: prospective multicenter observational study.

Authors:  J Turtiainen; E Saimanen; T Partio; J Kärkkäinen; V Kiviniemi; K Mäkinen; T Hakala
Journal:  Scand J Surg       Date:  2010       Impact factor: 2.360

2.  On reducing abnormal hemodynamics in the femoral end-to-side anastomosis: the influence of mechanical factors.

Authors:  Thomas O Brien; Michael Walsh; Tim McGloughlin
Journal:  Ann Biomed Eng       Date:  2005-03       Impact factor: 3.934

3.  Significance of ankle brachial index and collaterals for prediction of critical limb ischemia in infrainguinal peripheral arterial occlusive disease.

Authors:  A Zimmermann; C Roenneberg; C Reeps; H Wendorff; M Wildgruber; H H Eckstein
Journal:  Adv Med Sci       Date:  2011       Impact factor: 3.287

4.  Patency of infrainguinal polytetrafluoroethylene bypass grafts with distal interposition vein cuffs.

Authors:  P J Pappas; R W Hobson; M G Meyers; Z Jamil; B C Lee; M B Silva; M C Goldberg; F T Padberg
Journal:  Cardiovasc Surg       Date:  1998-02

5.  The impact of adjunctive iliac stenting on femoral-femoral bypass in contemporary practice.

Authors:  Chetan P Huded; Philip P Goodney; Richard J Powell; Brian W Nolan; Eva M Rzucidlo; Samuel T Simone; Daniel B Walsh; David H Stone
Journal:  J Vasc Surg       Date:  2012-01-05       Impact factor: 4.268

6.  Wound Disruption after Lower Extremity Bypass Surgery is a Predictor of Subsequent Development of Wound Infection.

Authors:  Faisal Aziz; Tiffany Bohr; Erik B Lehman
Journal:  Ann Vasc Surg       Date:  2017-03-11       Impact factor: 1.466

7.  A comparative evaluation of externally supported polytetrafluoroethylene axillobifemoral and axillounifemoral bypass grafts.

Authors:  C R Mohan; W J Sharp; J J Hoballah; T F Kresowik; M T Schueppert; J D Corson
Journal:  J Vasc Surg       Date:  1995-05       Impact factor: 4.268

8.  Prosthetic Graft Patency in the Setting of a Polymicrobial Infection in Swine (Sus scrofa).

Authors:  Mamie C Stull; Michael S Clemens; Thomas A Heafner; John Devin B Watson; Zachary M Arthurs; Brandon W Propper
Journal:  Ann Vasc Surg       Date:  2016-07-15       Impact factor: 1.466

Review 9.  Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.

Authors:  Rachel Bedenis; Anne Lethaby; Heather Maxwell; Stefan Acosta; Martin H Prins
Journal:  Cochrane Database Syst Rev       Date:  2015-02-19

10.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

View more
  1 in total

1.  Combined Coronary Artery Bypass Grafting and Extra-anatomic Ascending Aorta to Bifemoral Grafting Through Median Sternotomy.

Authors:  Mohammed Al-Musawi; Michelle M Dugan; Levonti Ohanisian; David Rubay; Ali N Abed
Journal:  Cureus       Date:  2019-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.